Table 2. Validated DLBCL subtype signature genes.
| Gene Name | Gene Description | GCB Read Counts | ABC Read Counts | Fold Change | FDR |
|---|---|---|---|---|---|
| ABC signature | |||||
| BCL2 | B-cell CLL/lymphoma 2 | 4,599.52 | 22,162.49 | 4.82 | 4.90E-05 |
| CCND2 | Cyclin D2 | 31.20 | 3692.67 | 118.60 | 1.56E-18 |
| CFLAR | CASP8 and FADD-like apoptosis regulator | 460.63 | 6463.37 | 14.03 | 5.52E-09 |
| FOXP1 | forkhead box P1 | 1202.37 | 6588.56 | 5.46 | 1.13E-04 |
| IRF4 | Interferon regulatory factor 4 | 976.01 | 21,475.28 | 22.01 | 2.43E-14 |
| NFKBIZ | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 962.34 | 8119.55 | 8.46 | 5.63E-06 |
| GCB signature | |||||
| BCL6 | B-cell CLL/lymphoma 6 | 15,105.68 | 5124.25 | 0.34 | 1.94E-02 |
| MAPK10 | Mitogen-activated protein kinase 10 | 1473.10 | 57.42 | 0.04 | 4.45E-05 |
| MME (CD10) | Membrane metallo-endopeptidase | 6163.64 | 663.16 | 0.11 | 6.01E-05 |
| MYBL1 | v-myb myeloblastosis viral oncogene homolog (avian)-like 1 | 2932.21 | 661.39 | 0.23 | 4.99E-02 |
DLBCL, diffuse large B-cell lymphoma; GCB, germinal center B-cell-like; ABC, activated B-cell-like; FDR, false-discovery rate; CLL, chronic lymphocytic leukemia.